Endocyte Presents Data On EC145 In Treatment Of Ovarian Cancer

Endocyte, Inc., a cancer drug discovery and development company, presented data from a Phase 2a clinical trial for EC145, currently in development as a potential treatment for advanced ovarian cancer.